AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 2904371
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg sublingual tablet formulation of temazepam
Trial: 2904371
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg oral capsule formulation of temazepam
Trial: 31641948
Drug: Polymorphonuclear neutrophil
RxNorm normalized name: Polymorphonuclear neutrophil elastase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polymorphonuclear neutrophil (PMN) count (> 6000/mm3 vs. ≤ 6000/mm3) before chemotherapy
Trial: 31641948
Drug: FOLFOX-based chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FOLFOX-based chemotherapy regimen
Trial: 25495134
Drug: Ibuprofen 800
RxNorm normalized name: ibuprofen 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen 800 mg and famotidine 26.6 mg
Trial: 16893694
Drug: Biolimus A9
RxNorm normalized name: Sirolimus
DrugBank: Sirolimus (DB00877)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Biolimus A9 drug-eluting stent
Trial: 15082989
Drug: Oxycodone or
RxNorm normalized name: oxycodone Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxycodone or hydrocodone
Trial: 8222513
Drug: Arginine vasopressin
RxNorm normalized name: 1-deamino-8-D-arginine vasopressin
DrugBank: Desmopressin (DB00035)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Arginine vasopressin infusion
Trial: 3951807
Drug: Half-dose Amicar
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Half-dose Amicar (50 mg/kg every four hours for five days, up to a maximum of 30 g/day)
Trial: 3951807
Drug: Full-dose Amicar
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Full-dose Amicar (100 mg/kg every four hours, up to a maximum of 30 g/day)
Trial: 3951807
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups (Half-dose and Full-dose)
Trial: 3951807
Drug: Both dose
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both dose levels of Amicar
Trial: 3951807
Drug: Prior aspirin
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prior aspirin ingestion
Trial: 29557487
Drug: Control (Tramadol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (Tramadol hydrochloride tablets)
Trial: 29750367
Drug: Choline supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Choline supplementation (2 g daily)
Trial: 25649051
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg OPC
Trial: 25649051
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg OPC
Trial: 25649051
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg OPC
Trial: 25012176
Drug: rt-PA/heparin (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rt-PA/heparin (1 mg per lumen, once per week)
Trial: 25012176
Drug: heparin alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: heparin alone (thrice-weekly)
Trial: 25012176
Drug: rt-PA/heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rt-PA/heparin
Trial: 19523170
Drug: Pseudocatalase cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pseudocatalase cream with NB‐UVB
Trial: 17035933
Drug: Continuous paroxetine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous paroxetine treatment
Trial: 17035933
Drug: Intermittent paroxetine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent paroxetine treatment (luteal phase only)
Trial: 16304269
Drug: IV azithromycin
RxNorm normalized name: Azithromycin
DrugBank: Azithromycin (DB00207)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: IV azithromycin plus IV ceftriaxone followed by oral azithromycin
Trial: 16304269
Drug: IV levofloxacin
RxNorm normalized name: Levofloxacin
DrugBank: Levofloxacin (DB01137)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: IV levofloxacin followed by oral levofloxacin
Trial: 1643914
Drug: Pulsed-release albuterol
RxNorm normalized name: albuterol Extended Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pulsed-release albuterol sulfate (8 mg)
Trial: 6383749
Drug: Gentamicin 2.4
RxNorm normalized name: gentamicin 2.4 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gentamicin 2.4 mg/kg at 12‐ or 18‐hour dosing intervals
Trial: 29374469
Drug: Propofol/remifentanil (4-6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol/remifentanil (4-6 mg/kg/h)
Trial: 27310330
Drug: PTC299 (0.03
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PTC299 (0.03 to 3 mg/kg single dose)
Trial: 27310330
Drug: PTC299 (0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PTC299 (0.3 to 1.2 mg/kg twice a day or 1.6 mg/kg 3 times a day for 7 days)
Trial: 22404324
Drug: Levofloxacin (therapeutic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levofloxacin (therapeutic dose 750 mg)
Trial: 22404324
Drug: Levofloxacin (low
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levofloxacin (low dose 7.5 mg)
Trial: 22404324
Drug: Cyclosporine (therapeutic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclosporine (therapeutic dose 200 mg)
Trial: 22404324
Drug: Cyclosporine (low
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclosporine (low dose 2 mg)
Trial: 12856809
Drug: Compound Nylestriol
RxNorm normalized name: BENZOIN COMPOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Compound Nylestriol Tablet (CNT) - 0.5 mg nylestriol and 0.15 mg levonorgestrel, one tablet per week for one year
Trial: 7851278
Drug: Buprenorphine (high-dose,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buprenorphine (high-dose, 3 day regimen)
Trial: 2682412
Drug: Patient-controlled administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patient-controlled administration of 10 mg meperidine every 20 minutes
Trial: 2682412
Drug: Nurse-administered meperidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nurse-administered meperidine (25-50 mg every 3 hours as requested)
Trial: 2682412
Drug: Patient-controlled administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patient-controlled administration of meperidine
Trial: 338400
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg daily of maprotiline (Ludiomil) administered once or thrice daily
Trial: 338400
Drug: 75 mg
RxNorm normalized name: talc 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 mg daily of maprotiline (Ludiomil) administered once or thrice daily
Trial: 338400
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg three times daily of maprotiline (Ludiomil)
Trial: 338400
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg thrice daily of maprotiline (Ludiomil)
Trial: 338400
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg nocte of maprotiline (Ludiomil)
Trial: 31915160
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg lithium carbonate
Trial: 25855884
Drug: Calfactant administration
RxNorm normalized name: Calfactant
DrugBank: Calfactant (DB06415)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calfactant administration
Trial: 23765945
Drug: B-vitamins (folic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: B-vitamins (folic acid, 2 mg; vitamin B6, 25 mg; vitamin B12, 500 μg)
Trial: 21147261
Drug: Warfarin continuation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warfarin continuation
Trial: 21147261
Drug: Warfarin interruption
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warfarin interruption
Trial: 8174496
Drug: Cefazolin (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefazolin (1 g q 8 h i.v.)
Trial: 28576557
Drug: Standard of
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard of care with saline heparin locks (Control)
Trial: 22320849
Drug: Baseline oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baseline oral health-related knowledge, attitudes, and beliefs regarding caries control.
Trial: 15996346
Drug: Allergy Guard
RxNorm normalized name: Clinda-Guard
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Allergy Guard (topical cream containing zinc gel)
Trial: 10343146
Drug: Pantoprazole 40
RxNorm normalized name: pantoprazole 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pantoprazole 40 mg b.i.d., clarithromycin 500 mg b.i.d. and amoxicillin 1,000 mg b.i.d. for 7 days
Trial: 6807149
Drug: DSGN nebulized
RxNorm normalized name: Hydra-Neb
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DSGN nebulized solution
Trial: 25119950
Drug: Varilrix(®) +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Varilrix(®) + cyclosporine (2.5 mg/kg/day)
Trial: 25119950
Drug: Subcutaneous saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous saline + cyclosporine (2.5 mg/kg/day)
Trial: 17919215
Drug: 0.1 mL
RxNorm normalized name: ethanol 0.1 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1 mL intradermal 1% lignocaine
Trial: 15449549
Drug: Octreotide administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Octreotide administration
Trial: 9745451
Drug: Spironolactone (MR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spironolactone (MR antagonist)
Trial: 9745451
Drug: Spironolactone (two
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spironolactone (two doses)
Trial: 7836162
Drug: 10% glucose
RxNorm normalized name: Dextrose 10% Oral Solution [SIMILAC 10% GLUCOSE WATER]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10% glucose solution containing 6‐[3H]glucose (CHO)
Trial: 2831524
Drug: Atenolol (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol (10 mg IV every six hours for three days, then 100 mg orally once a day for four days)
Trial: 23090678
Drug: 2.5 mg
RxNorm normalized name: biotin 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 mg daily oral ibandronate (n = 40)
Trial: 23090678
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg intermittent oral ibandronate (n = 34)
Trial: 23090678
Drug: Oral placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral placebo (n = 36)
Trial: 20380480
Drug: Fosamprenavir/ritonavir (FPV/r)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fosamprenavir/ritonavir (FPV/r) 1400 mg/100 mg
Trial: 20380480
Drug: Atazanavir/ritonavir (ATV/r)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atazanavir/ritonavir (ATV/r) 300 mg/100 mg
Trial: 18652000
Drug: Standard pre-chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard pre-chemotherapy education
Trial: 10832917
Drug: Ondansetron (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ondansetron (4 microg/kg twice a day) + Naltrexone (25 mg twice a day)
Trial: 9093956
Drug: Questionnaire on
RxNorm normalized name: Gel-One
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Questionnaire on visual tasks in daily living
Trial: 8475558
Drug: Prostaglandin E1
RxNorm normalized name: Prostaglandin E1
DrugBank: Alprostadil (DB00770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prostaglandin E1 infusion (PG group)
Trial: 2881461
Drug: HSR-902 (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HSR-902 (30 mg daily for 7 days)
Trial: 2881461
Drug: Butylscopolamine bromide
RxNorm normalized name: Butylscopolamine Bromide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Butylscopolamine bromide (60 mg daily for 7 days)
Trial: 27142448
Drug: Green tea
RxNorm normalized name: Green Tea
DrugBank: Green tea leaf (DB14307)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Green tea (2 g/day, containing 220.2 mg of catechins)
Trial: 27142448
Drug: Placebo (0.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (0.0 mg of catechins)
Trial: 25877963
Drug: efavirenz 600
RxNorm normalized name: efavirenz 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: efavirenz 600 mg
Trial: 21313892
Drug: Oral clonidine
RxNorm normalized name: Clonidine
DrugBank: Clonidine (DB00575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral clonidine (0.2 mg)
Trial: 11823923
Drug: Acetylcholinesterase Inhibitors
RxNorm normalized name: acetylcholinesterase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetylcholinesterase Inhibitors (AChEI)
Trial: 9817530
Drug: Sequential therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential therapy with zidovudine, didanosine and zalcitabine
Trial: 9817530
Drug: Monotherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monotherapy with zidovudine
Trial: 7711990
Drug: Epidural meperidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural meperidine 1 mg kg‐1
Trial: 7711990
Drug: Epidural pentazocine
RxNorm normalized name: Pentazocine
DrugBank: Pentazocine (DB00652)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Epidural pentazocine 0.3 mg kg‐1
Trial: 2674395
Drug: Antimicrobial agent
RxNorm normalized name: GAUZE,ANTIMICROBIAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antimicrobial agent delivered by an oral irrigating device
Trial: 31106377
Drug: Rifampicin plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rifampicin plus β‐lactam antibiotics
Trial: 31106377
Drug: β‐lactam antibiotics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: β‐lactam antibiotics only
Trial: 23443901
Drug: Interfascial bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interfascial bupivacaine administration
Trial: 23443901
Drug: Suprafascial bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Suprafascial bupivacaine administration
Trial: 21314871
Drug: Duloxetine treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Duloxetine treatment for fibromyalgia and CLBP
Trial: 21314871
Drug: Duloxetine treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Duloxetine treatment for DPNP
Trial: 17824890
Drug: Early loading
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early loading of mandibular implant overdentures delivered 1 week after surgery
Trial: 17824890
Drug: Conventional mandibular
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional mandibular prostheses converted to mandibular implant overdentures 3 months after surgery
Trial: 17824890
Drug: Prosthodontic maintenance
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prosthodontic maintenance of the mandibular implant overdentures in the first year
Trial: 10730079
Drug: Preoperative epidural
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preoperative epidural morphine 2 mg at T 6‐7 and 2 mg at L 3‐4
Trial: 10730079
Drug: Continuous thoracic
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous thoracic epidural infusion of 1% lidocaine (lidocaine group, n = 15)
Trial: 10730079
Drug: Continuous thoracic
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous thoracic epidural infusion of normal saline solution (control group, n = 15)
Trial: 7357821
Drug: Elemental diet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Elemental diet supplements
Trial: 25965082
Drug: Low-dose prophylactic
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose prophylactic corticosteroid (PCS) starting dose 15 mg/day of prednisolone for 6 weeks (PCS-On group)
Trial: 25965082
Drug: Thyroid-stimulating antibody
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thyroid-stimulating antibody
Trial: 21279975
Drug: Standard PDT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard PDT (10‐minute 6 mg/mq2 verteporfin infusion; treatment at 15 min; 50 J/cm2; 83 s)
Trial: 21279975
Drug: Bolus PDT
RxNorm normalized name: Peumus boldus leaf extract
DrugBank: Boldo leaf extract (DB15815)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bolus PDT (6 mg/mq2 verteporfin infusion bolus in 1 min; treatment at 5 min; 100 J/cm2; 166 s)
Trial: 8083077
Drug: Cohort 2:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cohort 2: Three completed cycles of chemotherapy and radiotherapy
Trial: 26277524
Drug: HBO therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HBO therapy at 0.175 MPa
Trial: 26277524
Drug: HBO therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HBO therapy at 0.2 MPa
Trial: 26277524
Drug: HBO therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HBO therapy at 0.175 MPa and 0.2 MPa
Trial: 21501481
Drug: Adjuvant chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant chemotherapy of lower intensity with CMF
Trial: 21501481
Drug: Adjuvant chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant chemotherapy with CAF
Trial: 21501481
Drug: Hormonal therapy
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hormonal therapy alone following surgery and/or radiation therapy
Trial: 8860064
Drug: Nisoldipine therapy
RxNorm normalized name: Nisoldipine
DrugBank: Nisoldipine (DB00401)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nisoldipine therapy
Trial: 3087307
Drug: Cefotaxime sodium
RxNorm normalized name: Cefotaxime Sodium
DrugBank: Cefotaxime (DB00493)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefotaxime sodium at a dosage of 12 g/day
Trial: 24087989
Drug: Low molecular
RxNorm normalized name: Low molecular weight heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low molecular weight heparin (LMWH; nadroparin) for 1 week
Trial: 24087989
Drug: Low molecular
RxNorm normalized name: Low molecular weight heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low molecular weight heparin (LMWH; nadroparin)
Trial: 22439781
Drug: Tigecycline (TGC)
RxNorm normalized name: Tigecycline
DrugBank: Tigecycline (DB00560)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tigecycline (TGC) 100 mg followed by 50 mg q 12 h
Trial: 22439781
Drug: Ceftriaxone plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftriaxone plus Metronidazole (CTX/MET) 2 g qd plus 1-2 g daily
Trial: 20733444
Drug: 20 international
RxNorm normalized name: CONDOM,INTERNAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 international units oxytocin diluted with 26 mL saline
Trial: 20733444
Drug: 30 mL
RxNorm normalized name: Vial M/T 30 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mL saline (placebo)
Trial: 12534515
Drug: 585‐nm pulsed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 585‐nm pulsed dye laser (PDL) treatment on one scar half
Trial: 12534515
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no treatment on the other scar half)
Trial: 12534515
Drug: 585‐nm pulsed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 585‐nm pulsed dye laser (PDL) treatment
Trial: 2971274
Drug: Preservative free
RxNorm normalized name: preservative free
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preservative free ipratropium bromide nebuliser solution
Trial: 2971274
Drug: Atrovent nebuliser
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atrovent nebuliser solution
Trial: 28404008
Drug: Surgical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical treatment (resection)
Trial: 26546405
Drug: Aripiprazole 15
RxNorm normalized name: aripiprazole 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aripiprazole 15 mg orally disintegrating tablet (ODT) without water
Trial: 26546405
Drug: Conventional aripiprazole
RxNorm normalized name: Aripiprazole
DrugBank: Aripiprazole (DB01238)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Conventional aripiprazole 15 mg standard tablet with 240 mL water
Trial: 21802823
Drug: ASA therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ASA therapy suspended 7 days before tooth extraction (group S)
Trial: 21802823
Drug: ASA therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ASA therapy unaltered (group NS)
Trial: 21802823
Drug: ASA therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ASA therapy suspended (group S)
Trial: 16936457
Drug: Hyperbaric oxygen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyperbaric oxygen therapy combined with intravenous edaravone administration for 7 days
Trial: 11401940
Drug: Gemfibrozil 1200
RxNorm normalized name: Gemfibrozil
DrugBank: Gemfibrozil (DB01241)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Gemfibrozil 1200 mg/d
Trial: 11327443
Drug: High-dose didanosine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose didanosine
Trial: 8217757
Drug: Cyclosporin (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclosporin (5 mg/kg/day)
Trial: 3104249
Drug: Radiation therapy
RxNorm normalized name: Sensitizers used in photodynamic/radiation therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiation therapy plus Misonidazole (MISO) (400 mg/m2 daily 2 to 4 hours prior to radiation therapy)
Trial: 3104249
Drug: Radiation therapy
RxNorm normalized name: Sensitizers used in photodynamic/radiation therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiation therapy alone (4600 cGy pelvis plus 1000 cGy parametrial boost)
Trial: 25923150
Drug: Intramuscular diclofenac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular diclofenac 75 mg and sublingual methylcobalamin
Trial: 25923150
Drug: Sublingual piroxicam
RxNorm normalized name: Piroxicam
DrugBank: Piroxicam (DB00554)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sublingual piroxicam 40 mg and intramuscular distilled water